UBE2F-SAG Mediated RHEB Neddylation Drives mTORC1 in Liver C
2026-04-20
This study identifies RHEB as a direct neddylation substrate of the UBE2F-SAG enzymatic axis, revealing a novel regulatory mechanism for mTORC1 activation in liver tumorigenesis. These findings present the UBE2F-SAG-RHEB pathway as a potential target for hepatocellular carcinoma and metabolic liver disease intervention.
Metronidazole: Applied OAT3 Inhibition & Microbiota Modulati
2026-04-20
Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) from APExBIO is a dual-function tool for research on organic anion transporter inhibition and microbiota-immune interactions. This guide delivers actionable workflows, advanced use-cases, and troubleshooting strategies to maximize the impact of Metronidazole in gut-immune and drug-drug interaction studies.
DMXAA (Vadimezan): Optimizing Tumor Vasculature Disruption A
2026-04-19
DMXAA (Vadimezan) empowers researchers to dissect tumor vasculature disruption and apoptosis induction in oncology models, thanks to its dual DT-diaphorase and VEGFR2 inhibition. This guide delivers actionable protocols, troubleshooting strategies, and translational insights rooted in cutting-edge research, ensuring robust, reproducible results.
Pharmacokinetic Variability of CSBTA in MASH: Mechanistic In
2026-04-18
This study investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of major Corydalis saxicola Bunting total alkaloids in mice. The findings reveal that disease status, dosing regimen, and transporter/enzyme modulation collectively influence systemic exposure and hepatic accumulation, providing a framework for optimizing therapeutic strategies in MASLD/MASH.
Technical Guide: DiI (DiIC18(3)) Plasma Membrane Orange Fluo
2026-04-17
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe addresses the challenge of high-contrast, specific plasma membrane labeling for neuronal tracing, cell migration, and membrane dynamics assays. It is not suitable for water-based applications or for labeling organelles beyond the plasma membrane, and careful protocol adherence is required for reproducible results.
Integrated Workflow for mRNA Lipid Nanoparticle Formulation
2026-04-16
Ma et al. present a comprehensive, stepwise protocol for the formulation, characterization, and evaluation of mRNA lipid nanoparticles (LNPs), addressing a critical need for standardized workflows in mRNA delivery research. By uniting formulation, analytical characterization, and in vitro/in vivo evaluation within a single protocol, the study lowers technical barriers and supports reproducible development of mRNA-based therapeutics.
Chlorambucil: Applied Workflows for DNA Crosslinking Assays
2026-04-15
Chlorambucil, a nitrogen mustard alkylating agent, offers unique advantages for in vitro DNA damage, apoptosis, and cytotoxicity workflows. This article translates current evidence and reference innovations into actionable protocols and troubleshooting for cancer research, maximizing assay reproducibility and data depth.
YAP-TEAD Orchestrates Super-Enhancer Networks in Surface Ect
2026-04-14
This study delineates how the YAP-TEAD transcriptional complex regulates super-enhancer (SE) architecture to control early commitment of surface ectoderm from pluripotent stem cells. By integrating 3D genome mapping and targeted CRISPR perturbations, the work uncovers SE-driven transcriptional networks essential for epithelial lineage specification, offering mechanistic insights relevant for stem cell-based regenerative approaches.
Mifepristone (RU486): Advanced Protocols for Cancer & Reprod
2026-04-13
Mifepristone (RU486) from APExBIO enables precise, reproducible modulation of progesterone receptor signaling in oncology and reproductive research. This guide delivers actionable protocols, troubleshooting insights, and workflow enhancements to elevate your experimental impact.
Alfuzosin HCl in BPH Research: Protocols, Troubleshooting, a
2026-04-12
Alfuzosin HCl is a benchmark α1 adrenoceptor antagonist for benign prostatic hyperplasia research, offering robust uroselectivity and an exceptional safety profile. This article translates recent advances into actionable workflows, highlighting troubleshooting tips and comparative advantages for experimental design.
VX-661: Optimizing F508del CFTR Corrector Workflows in CF Re
2026-04-12
VX-661 (F508del CFTR corrector) is a pivotal tool for restoring CFTR function in cystic fibrosis research, especially for F508del and related variants. This article delivers actionable protocol enhancements, troubleshooting strategies, and evidence-driven insights—empowering researchers to achieve reproducible, high-efficiency CFTR modulation in vitro.
Ampicillin Sodium: Optimizing β-Lactam Antibiotic Workflows
2026-04-11
Ampicillin sodium from APExBIO delivers reproducible results in antibacterial activity assays and recombinant protein workflows. This guide translates benchmark research and vendor insights into applied protocols, troubleshooting, and advanced use-cases for effective bacterial cell wall biosynthesis inhibition.
3X (DYKDDDDK) Peptide: Precision in Affinity Purification Wo
2026-04-11
The 3X (DYKDDDDK) Peptide revolutionizes affinity purification and immunodetection with its triple-epitope design, boosting sensitivity and reproducibility in recombinant protein studies. Explore how its unique properties, including metal-dependent antibody binding, enable robust workflows from structural biology to metal-sensitive ELISA assays.
Triiodothyronine (T3) as a Strategic Catalyst: Harnessing...
2026-04-10
This thought-leadership article synthesizes emerging mechanistic insights—such as SEMA3E-driven beige adipocyte thermogenesis and β-catenin signaling—with practical guidance for translational researchers using triiodothyronine (T3). Bridging foundational endocrinology, advanced disease models, and product intelligence from APExBIO, it offers a visionary roadmap for leveraging T3 in metabolic regulation, gene expression modulation, and thyroid hormone receptor activation assays. By integrating recent primary literature and internal resources, the article both contextualizes and escalates the discussion beyond standard product pages, delivering actionable strategies for innovation in metabolic disorder research.
Triiodothyronine (T3): Advanced Mechanistic Insights for ...
2026-04-09
Discover how Triiodothyronine (T3) fuels advanced thyroid hormone signaling pathway research and cellular metabolism assays. This article delivers novel mechanistic perspectives, integrating cutting-edge adipocyte differentiation findings for a deeper understanding of metabolic regulation.
467 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page